Work

Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancer.

Year: 1999

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: J E Portielje, W H Kruit, M Schuler, J Beck, C H Lamers, G Stoter, C Huber, M de Boer-Dennert, A Rakhit, R L Bolhuis, W E Aulitzky

Institution: Johannes Gutenberg University Mainz

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2145110081

FWCI: 3.473

Cites: 26

Cited by: 117

Related to: 10